Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Men with severe hair loss may have a higher risk of heart disease.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Combination therapy is better for long-term control and outcomes in type 2 diabetes.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Propranolol can cause reversible hair loss.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

The Princeton III Consensus recommends assessing cardiovascular risk in men with erectile dysfunction and prioritizing heart health before treating ED, especially in those with potential heart disease.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Hair loss linked to higher heart disease risk in both men and women.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

Hair loss may indicate higher heart risk and metabolic issues.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

Women with irregular periods have a higher risk of heart disease.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Severe hair loss (androgenetic alopecia) is linked to higher risk of heart disease (cardiovascular atherosclerosis).

AGA patients have higher heart disease risk.

People with vitiligo may have a lower risk of heart disease.

High doses of minoxidil can harm marmoset hearts and kidneys, possibly affecting humans similarly.

After moderate COVID-19, cardiovascular patients had fewer respiratory issues but faced new physical and psychological problems.

Hair loss may increase heart disease risk.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Human hair protein modifications could potentially indicate heart disease risk.

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

Statins may be linked to reproductive organ conditions, and their risks should be monitored.